Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice

American Heart Journal

Volumn 135, Issue 5 I, 1998, Pages 786-796

  Becker, R C ^a   Burns, M ^a   Gore, J M ^a   Spencer, F A ^a   Ball, S P ^a   French, W ^a   Lambrew, C ^a   Bowlby, L ^a   Hilbe, J ^a   Rogers, W J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN DERIVATIVE; LIDOCAINE;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; ENZYME ANALYSIS; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 0031807686     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70036-5     Document Type: Article

References (36)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction Lancet 1 1986 397 402
2. ISIS-2 Second International Study of Infarct Survival Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2 Lancet 2 1988 349 360
3. RG Wilcox G von der Lippe CG Olsson G Jensen AM Skene JR. Hampton Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Lancet 2 1988 525 530
4. The GUSTO Angiographic Investigators The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction N Engl J Med 329 1993 1615 1622
5. RJ Simes EJ Topol DR Holmes for the GUSTO-1 Investigators Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion Circulation 91 1995 1923 1928
6. National Heart Lung Blood Institute Morbidity and mortality: chart-book on cardiovascular, lung and blood diseases May 1992 US Department of Health and Human Services, Public Health Service, National Institutes of Health Bethesda (MD)
7. National Heart Lung Blood Institute 9-1-1: Rapid identification and treatment of acute myocardial infarction May 1994 US Department of Health and Human Services, Public Health Service, National Institutes of Health Bethesda (MD) NIH publication 94-3302
8. National Heart Lung Blood Institute Patient/bystander recognition and action: rapid identification and treatment of acute myocardial infarction. National Heart Attack Alert Program (NHAAP) 1993 National Institutes of Health Bethesda (MD) NIH Publication No. 93-3303
9. CH Hennekens CM Albert SL Godfried JM Gaziano JE. Buring Adjunctive drug therapy of acute myocardial infarction—evidence from clinical trials N Eng J Med 335 1996 1660 1666
10. RJ. Krone The role of risk stratification in the early management of a myocardial infarction Ann Intern Med 116 1992 223 237
11. RW Parsons KD Jamrozik MS Hobbs PL. Thompson Early identification of patients at low risk of death after myocardial infarction and potentially suitable for early hospital discharge BMJ 308 1994 1006 1010
12. M Gheorghiade J Anderson H Rosman Risk identification at the time of admission to coronary care unit in patients with suspected myocardial infarction Am Heart J 116 1988 1212 1217
13. KL Lee LH Woodlief EJ Topol Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients Circulation 91 1995 1659 1668
14. JHA Prabhat D Deboer K Sykora CD. Naylor Characteristics and mortality outcomes of thrombolysis trial participants and nonparticipants: a population-based comparison J Am Coll Cardiol 27 1996 1335 1342
15. PB Berger DR Holmes AL Stebbins for the GUSTO-1 Investigators Impact of an aggresive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the GUSTO-1 trial Circulation 96 1997 122 127
16. JS Hochman J Boland LA Sleeper the SHOCK Registry Investigators Current spectrum of cardiogenic shock and effect of early revascularization on mortality Circulation 91 1995 873 881
17. RM Califf LH Woodleif FE Harrell Jr from the GUSTO-1 Investigations Selection of thrombolytic therapy for individual patients: development of a clinical model Am Heart J 133 1997 639 670
18. WJ Rogers LJ Bowlby NC Chandra Treatment of myocardial infarction in the United States (1990 to 1993): observations from the National Registry of Myocardial Infarction Circulation 90 1994 2103 2114
19. The TIMI Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial N Engl J Med 320 1989 618 627
20. E Braunwald CP Cannon CH. McCabe Use of composite end patients in thrombolysis trials of acute myocardial infarction Am J Cardiol 72 1993 36 126
21. Fibrinolytic Therapy Trialists' FTT Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients Lancet 343 1994 311 322
22. LK Newby RM Califf A Guerci Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial J Am Coll Cardiol 27 1996 625 632
23. L Pilote RM Califf S Sapp Regional variation across the United States in the management of acute myocardial infarction: GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries N Engl J Med 333 1995 565 572
24. F Van der Werf EJ Topol KL Kerry Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: results from the GUSTO trial JAMA 273 1995 1586 1591
25. TP Meehan J Hennen MJ Radford MK Petrillo P Elstein DJ. Ballard Process and outcome of care for acute myocardial infarction among Medicare beneficiaries in Connecticut: a quality improvement demonstration project Ann Intern Med 122 1995 928 936
26. EB Keeler LV Rubenstein KL Kahn D Draper ER Harrison MJ McGinty WH Rogers RH. Brook Hospital characteristics and quality of care JAMA 268 1992 1709 1714
27. KL Kahn WH Rogers LV Rubenstein M Sherwood EJ Reinisch EB Keeler Measuring quality of care with explicit process criteria before and after implementation of the DRG-based prospective payment system JAMA 264 1990 1969 1973
28. J Mant N. Hicks Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction BMJ 311 1995 793 796
29. J Van Ruiswyk A Hartz E Kuhn H Krakauer M Young A. Rimm A measure of mortality risk for elderly patients with acute myocardial infarction Med Decis Making 13 1993 152 160
30. S-LT Normand ME Glickman RG Sharwa BJ. McNeil Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the cooperative cardiovascular project JAMA 275 1996 1322 1328
31. CL Grines KF Browne J Marco A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 328 1993 673 679
32. N Every WD Weaver L Parsons JS Martin for the MITI Project Investigators Direct PTCA vs thrombolysis: immediate and one year outcome and procedure utilization for the two treatment strategies [abstract] Circulation 92 Suppl I 1995 I-138
33. SG Ellis ER da Silva G Heyndrickx Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction Circulation 90 1994 2280 2284
34. ACC/AHA guidelines for the management of patients with acute myocardial infarction A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 28 1996 1328 1428
35. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
36. L Pilote DP Miller RM Califf JS RAO WD Weaver EJ Topol Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction N Engl J Med 335 1996 1198 1205